Pyxis Oncology, Inc. (PYXS) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $15.42M | -20.8% |
| 2024 | $19.47M | +101.5% |
| 2023 | $9.66M | -94.6% |
| 2022 | $179.29M | -34.7% |
| 2021 | $274.74M | +3300.2% |
| 2020 | $8.08M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $15.42M | -20.8% |
| 2024 | $19.47M | +101.5% |
| 2023 | $9.66M | -94.6% |
| 2022 | $179.29M | -34.7% |
| 2021 | $274.74M | +3300.2% |
| 2020 | $8.08M | — |